NCT06358469View on ClinicalTrials.gov

STRatIfication of Vulvar SCC by HPV and p53 Status to Guide Excision

NARecruitingINTERVENTIONAL
Enrollment

249

Participants

Timeline

Start Date

December 10, 2024

Primary Completion Date

June 30, 2030

Study Completion Date

November 30, 2031

Conditions
Vulvar Squamous Cell Carcinoma
Interventions
PROCEDURE

Surgery

Re-excision of vulvar cancer margin

OTHER

Active Surveillance

The investigator will follow the patient to watch for side effects and keep track of patient's health

Trial Locations (5)

V5Z 4E6

RECRUITING

BCCA - Vancouver, Vancouver

L8V 5C2

RECRUITING

Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton

M4N 3M5

RECRUITING

Odette Cancer Centre, Toronto

H2X 3E4

RECRUITING

CHUM-Centre Hospitalier de l'Universite de Montreal, Montreal

G1R 2J6

RECRUITING

Hotel-Dieu de Quebec, Québec

All Listed Sponsors
collaborator

Australia New Zealand Gynaecological Oncology Group

OTHER

lead

Canadian Cancer Trials Group

NETWORK